Literature DB >> 15121032

HDL: a recipe for longevity.

Philip Barter1.   

Abstract

The concentration of high density lipoprotein cholesterol (HDL-C) has been found to be a powerful negative predictor of premature coronary heart disease (CHD) and stroke in human prospective population studies. Evidence of the protective properties of HDLs has also been documented in the elderly and their offspring. HDLs mediate several functions that provide an insight into their potential anti-atherogenic mechanisms. Intervention strategies to prevent CHD have generally focused on lowering low-density lipoprotein cholesterol (LDL-C). However, several lifestyle and pharmacological interventions have the capacity to raise the level of HDL-C. As data accumulate on the protective role of HDLs, there is growing support for interventions that act to raise HDL-C concentrations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121032     DOI: 10.1016/j.atherosclerosissup.2004.03.003

Source DB:  PubMed          Journal:  Atheroscler Suppl        ISSN: 1567-5688            Impact factor:   3.235


  11 in total

1.  Lower HDL-cholesterol among healthy middle-aged Japanese-Brazilians in São Paulo compared to Natives and Japanese-Brazilians in Japan.

Authors:  Andiara Schwingel; Yoshio Nakata; Lucy S Ito; Wojtek J Chodzko-Zajko; Ryosuke Shigematsu; Christopher T Erb; Simone M Souza; Sueli M Oba-Shinjo; Tomoaki Matsuo; Suely K N Marie; Kiyoji Tanaka
Journal:  Eur J Epidemiol       Date:  2007-01-17       Impact factor: 8.082

2.  Klotho locus, metabolic traits, and serum hemoglobin in hospitalized older patients: a genetic association analysis.

Authors:  Giulia Paroni; Davide Seripa; Francesco Panza; Filomena Addante; Massimiliano Copetti; Grazia D'Onofrio; Fabio Pellegrini; Luigi Fontana; Alberto Pilotto
Journal:  Age (Dordr)       Date:  2011-06-22

3.  Low high-density lipoprotein 3 reduces the odds of men surviving to age 85 during 53-year follow-up.

Authors:  Paul T Williams
Journal:  J Am Geriatr Soc       Date:  2012-02-13       Impact factor: 5.562

4.  High-density lipoprotein cholesterol and objective measures of lower extremity performance in older nondisabled persons: the InChianti study.

Authors:  Stefano Volpato; Alessandro Ble; E Jeffrey Metter; Fulvio Lauretani; Stefania Bandinelli; Giovanni Zuliani; Renato Fellin; Luigi Ferrucci; Jack M Guralnik
Journal:  J Am Geriatr Soc       Date:  2008-01-16       Impact factor: 5.562

Review 5.  Gene activation regresses atherosclerosis, promotes health, and enhances longevity.

Authors:  Pauli V Luoma
Journal:  Lipids Health Dis       Date:  2010-07-06       Impact factor: 3.876

Review 6.  Dyslipidemias in the prevention of cardiovascular disease: risks and causality.

Authors:  Ian Graham; Marie-Therese Cooney; David Bradley; Alexandra Dudina; Zeljko Reiner
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

7.  Location of PRODAN in lipid layer of HDL particle: a Raman study.

Authors:  D Krilov; M Balarin; M Kosović; J Brnjas-Kraljević
Journal:  Eur Biophys J       Date:  2008-02-07       Impact factor: 1.733

8.  Optimism and Lipid Profiles in Midlife: A 15-Year Study of Black and White Adults.

Authors:  Farah Qureshi; Jackie Soo; Ying Chen; Brita Roy; Donald M Lloyd-Jones; Laura D Kubzansky; Julia K Boehm
Journal:  Am J Prev Med       Date:  2022-01-20       Impact factor: 5.043

9.  Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.

Authors:  Rakesh S Birjmohun; Menno Vergeer; Erik S G Stroes; Manjinder S Sandhu; Sally L Ricketts; Michael W Tanck; Nicholas J Wareham; J Wouter Jukema; John J P Kastelein; Kay-Tee Khaw; S Matthijs Boekholdt
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

10.  Effect of DanQi Pill on PPARα, lipid disorders and arachidonic acid pathway in rat model of coronary heart disease.

Authors:  Hong Chang; Qiyan Wang; Tianjiao Shi; Kuiyuan Huo; Chun Li; Qian Zhang; Guoli Wang; Yuanyuan Wang; Binghua Tang; Wei Wang; Yong Wang
Journal:  BMC Complement Altern Med       Date:  2016-03-22       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.